Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NOP53 antisense RNA 1 (NOP53-AS1) is a long noncoding antisense RNA transcribed from the opposite strand of the NOP53 gene locus. Members of the antisense lncRNA family, such as NOP53-AS1, typically regulate their sense protein-coding gene (here, NOP53/GLTSCR2) through diverse mechanisms including chromatin remodeling, transcriptional control, mRNA stability, and modulation of translation. Antisense lncRNAs are often involved in cell proliferation, apoptosis, and metastasis, frequently functioning as either tumor suppressors or oncogenes, although specific data for NOP53-AS1 are lacking in the provided literature. Like other antisense lncRNAs, NOP53-AS1 may be differentially expressed in cancer and might play a regulatory role in tumorigenesis, but its clinical significance and functional impacts are not yet well established[2]. If you meant to inquire about the protein-coding gene NOP53 (GLTSCR2), which is a nucleolar protein with tumor suppressor function and is directly involved in p53 signaling and ribosome biogenesis, please clarify, as that is a distinct and better-characterized molecular entity[5].
None directly reported for drugs; possible mechanisms by which modulation could impact disease include regulation of gene transcription, epigenetic modulation, or RNA stability
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NOP53 antisense RNA 1 (NOP53-AS1).